A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo
Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.
Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.